{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:54:55Z","timestamp":1793091295302,"version":"4.5.0"},"reference-count":58,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2015]]},"DOI":"10.17116\/terarkh201587398-104","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T15:23:22Z","timestamp":1460647402000},"page":"98","source":"Crossref","is-referenced-by-count":2,"title":["Impact of respiratory viruses on the course of chronic obstructive pulmonary disease: Towards optimizing treatment"],"prefix":"10.26442","volume":"87","author":[{"given":"O. V.","family":"Kalyuzhin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. N.","family":"Chelenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zh. B.","family":"Ponezheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201587398-104-1","doi-asserted-by":"crossref","unstructured":"Yach D., Hawkes C., Gould C.L., Hofman K.J. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004; 291: 2616\u20142622.","DOI":"10.1001\/jama.291.21.2616"},{"key":"key-10.17116\/terarkh201587398-104-2","unstructured":"Bousquet J., Khaltaev N. (ed.) Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007. http:\/\/whqlibdoc.who.int\/publications\/2007\/9789241563468_eng.pdf."},{"key":"key-10.17116\/terarkh201587398-104-3","unstructured":"Landis S.H., Muellerova H., Mannino D.M. et al. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012\u20142013. Int J COPD 2014; 9: 597\u2014611."},{"key":"key-10.17116\/terarkh201587398-104-4","unstructured":"Central Intelligence Agency. The World Factbook 2013\u201414. Washington, DC: Central Intelligence Agency; 2014. https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/index.html."},{"key":"key-10.17116\/terarkh201587398-104-5","unstructured":"Federal'naya sluzhba gosudarstvennoi\u00a0statistiki. Chislennost' naseleniya Rossiiskoi Federatsii po polu i vozrastu na 1 yanvarya 2012 goda. http:\/\/www.gks.ru\/bgd\/regl\/B12_111\/Main.htm."},{"key":"key-10.17116\/terarkh201587398-104-6","doi-asserted-by":"crossref","unstructured":"Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.","DOI":"10.1371\/journal.pmed.0030442"},{"key":"key-10.17116\/terarkh201587398-104-7","doi-asserted-by":"crossref","unstructured":"Frickmann H., Jungblut S., Hirche T.O. et al. The influence of virus infections on the course of COPD. Eur J Microbiol Immunol (Bp) 2012; 2 (3): 176\u2014185.","DOI":"10.1556\/EuJMI.2.2012.3.2"},{"key":"key-10.17116\/terarkh201587398-104-8","unstructured":"Kalyuzhin O.V. Ostrye respiratornye virusnye infektsii: sovremennye vyzovy, protivovirusnyi otvet, immunoprofilaktika i immunoterapiya. M: Meditsinskoe informatsionnoe agentstvo 2014."},{"key":"key-10.17116\/terarkh201587398-104-9","unstructured":"Chuchalin A.G., Aisanov Z.R., Avdeev S.N. i dr. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu khronicheskoi obstruktivnoi bolezni legkikh. Rus med zhurn 2014; 5: 331\u2014347."},{"key":"key-10.17116\/terarkh201587398-104-10","unstructured":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease (Updated 2014). Global Initiative for Chronic Obstructive Lung Disease, Inc 2014."},{"key":"key-10.17116\/terarkh201587398-104-11","unstructured":"Global'naya strategiya diagnostiki, lecheniya i profilaktiki khronicheskoi obstruktivnoi bolezni legkikh (peresmotr 2011 g.). Per. s angl. Pod red. A.S. Belevskogo. M: Rossiiskoe respiratornoe obshchestvo 2012."},{"key":"key-10.17116\/terarkh201587398-104-12","doi-asserted-by":"crossref","unstructured":"Anthonisen N.R. OM-85 BV for COPD. Am J Respir Crit Care Med 1997; 156: 1713\u20141714.","DOI":"10.1164\/ajrccm.156.6.ed15-97"},{"key":"key-10.17116\/terarkh201587398-104-13","doi-asserted-by":"crossref","unstructured":"Collet J.P., Shapiro S., Ernst P. et al. Effect of an immunostimulating agent on acute exacerbations and hospitalizations in COPD patients. Am J Respir Crit Care Med 1997; 156: 1719\u20141724.","DOI":"10.1164\/ajrccm.156.6.9612096"},{"key":"key-10.17116\/terarkh201587398-104-14","unstructured":"Li J., Zheng J.P., Yuan J.P. et al. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chin Med J 2004; 117: 828\u2014834."},{"key":"key-10.17116\/terarkh201587398-104-15","doi-asserted-by":"crossref","unstructured":"Singanayagam A., Joshi P.V., Mallia P., Johnston S.L. Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Medicine 2012; 10: 27.","DOI":"10.1186\/1741-7015-10-27"},{"key":"key-10.17116\/terarkh201587398-104-16","doi-asserted-by":"crossref","unstructured":"Mohan A., Chandra S., Agarwal D. et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: A systematic review. Respirology 2010; 15: 536\u2014542.","DOI":"10.1111\/j.1440-1843.2010.01722.x"},{"key":"key-10.17116\/terarkh201587398-104-17","doi-asserted-by":"crossref","unstructured":"Wu X., Chen D., Gu X. et al. Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis. Mol Biol Reports 2014; 41 (7): 4743\u20144751.","DOI":"10.1007\/s11033-014-3345-9"},{"key":"key-10.17116\/terarkh201587398-104-18","doi-asserted-by":"crossref","unstructured":"Garcia-Aymerich J., Gomez F.P., Benet M. et al. Identification and prospective validation of clinically relevant chronic pulmonary disease (COPD) subtypes. Thorax 2011; 66 (5): 430\u2014437.","DOI":"10.1136\/thx.2010.154484"},{"key":"key-10.17116\/terarkh201587398-104-19","doi-asserted-by":"crossref","unstructured":"Hurst J.R., Vestbo J., Anzueto A. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363 (12): 1128\u20141138.","DOI":"10.1056\/NEJMoa0909883"},{"key":"key-10.17116\/terarkh201587398-104-20","doi-asserted-by":"crossref","unstructured":"Tashkin D.P. Frequent exacerbations of chronic obstructive pulmonary disease \u2014 a distinct phenotype? N Engl J Med 2010; 363 (12): 1183\u20141184.","DOI":"10.1056\/NEJMe1008184"},{"key":"key-10.17116\/terarkh201587398-104-21","doi-asserted-by":"crossref","unstructured":"Kherad O., Bridevaux P.-O., Kaiser L. et al. Is Acute Exacerbation of COPD (AECOPD) Related to Viral Infection Associated with Subsequent Mortality or Exacerbation Rate? Open Respir Med J 2014; 8: 18\u201421.","DOI":"10.2174\/1874306401408010018"},{"key":"key-10.17116\/terarkh201587398-104-22","doi-asserted-by":"crossref","unstructured":"Wedzicha J.A., Donaldson G.C. Natural history of successive COPD exacerbations. Thorax 2012; 67 (11): 935\u2014936.","DOI":"10.1136\/thoraxjnl-2012-202087"},{"key":"key-10.17116\/terarkh201587398-104-23","doi-asserted-by":"crossref","unstructured":"Seemungal T., Harper-Owen R., Bhowmik A. et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164 (9): 1618\u20141623.","DOI":"10.1164\/ajrccm.164.9.2105011"},{"key":"key-10.17116\/terarkh201587398-104-24","doi-asserted-by":"crossref","unstructured":"Ezzeldin N., Shalaby A., Saad-Hussein A., Ezzeldin H. Association of TNF-\u03b1 \u2014308G\/A, SP-B 1580 C\/T, IL-13 \u20141055 C\/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population. Arch Med Sci 2012; 8 (2): 286\u2014295.","DOI":"10.5114\/aoms.2012.28556"},{"key":"key-10.17116\/terarkh201587398-104-25","doi-asserted-by":"crossref","unstructured":"Bardin P.G., Sanderson G., Robinson B.S. et al. Experimental rhinovirus infection in volunteers. Eur Respir J 1996; 9: 2250\u20142255.","DOI":"10.1183\/09031936.96.09112250"},{"key":"key-10.17116\/terarkh201587398-104-26","doi-asserted-by":"crossref","unstructured":"Mallia P., Footitt J., Sotero R. et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186 (11): 1117\u20141124.","DOI":"10.1164\/rccm.201205-0806OC"},{"key":"key-10.17116\/terarkh201587398-104-27","doi-asserted-by":"crossref","unstructured":"Hutchinson A.F., Ghimire A.K., Thompson M.A. et al. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med 2007; 101: 2472\u20142481.","DOI":"10.1016\/j.rmed.2007.07.015"},{"key":"key-10.17116\/terarkh201587398-104-28","doi-asserted-by":"crossref","unstructured":"Short K.R., Habets M.N., Hermans P.W., Diavatopoulos D.A. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol 2012; 7 (5): 609\u2014624.","DOI":"10.2217\/fmb.12.29"},{"key":"key-10.17116\/terarkh201587398-104-29","doi-asserted-by":"crossref","unstructured":"Nishikawa T., Shimizu K., Tanaka T. et al. Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor. PLoS One 2012; 7 (9): e45371.","DOI":"10.1371\/journal.pone.0045371"},{"key":"key-10.17116\/terarkh201587398-104-30","doi-asserted-by":"crossref","unstructured":"Bosch A.A.T.M., Biesbroek G., Trzcinski K. et al. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog 2013; 9 (1): e1003057.","DOI":"10.1371\/journal.ppat.1003057"},{"key":"key-10.17116\/terarkh201587398-104-31","doi-asserted-by":"crossref","unstructured":"Ghoneim H.E., Thomas P.G., McCullers J.A. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol 2013; 191 (3): 1250\u20141259.","DOI":"10.4049\/jimmunol.1300014"},{"key":"key-10.17116\/terarkh201587398-104-32","doi-asserted-by":"crossref","unstructured":"Gavala M., Bertics P.J., Gern J.E. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev 2011; 242 (1): 69\u201490.","DOI":"10.1111\/j.1600-065X.2011.01031.x"},{"key":"key-10.17116\/terarkh201587398-104-33","unstructured":"Kalyuzhin O.V. Ostrye respiratornye virusnye infektsii: sovremennye vyzovy, novyi vzglyad na mesto induktorov interferonov v profilaktike i terapii. Lech vrach 2013; 9: 78\u201484."},{"key":"key-10.17116\/terarkh201587398-104-34","doi-asserted-by":"crossref","unstructured":"Shahangian A., Chow E.K., Tian X. et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119 (7): 1910\u20141920.","DOI":"10.1172\/JCI35412"},{"key":"key-10.17116\/terarkh201587398-104-35","doi-asserted-by":"crossref","unstructured":"Li W., Moltedo B., Moran T.M. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of \u03b3\u03b4 T cells. J Virol 2012; 86 (22): 12304\u201412312.","DOI":"10.1128\/JVI.01269-12"},{"key":"key-10.17116\/terarkh201587398-104-36","doi-asserted-by":"crossref","unstructured":"Eltom S., Dale N., Raemdonck K.R.G. et al. Respiratory Infections Cause the Release of Extracellular Vesicles: Implications in Exacerbation of Asthma\/COPD. PLoS One 2014; 9 (6): e101087.","DOI":"10.1371\/journal.pone.0101087"},{"key":"key-10.17116\/terarkh201587398-104-37","doi-asserted-by":"crossref","unstructured":"Lommatzsch M., Cicko S., M\u00fcller T. et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 928\u2014934.","DOI":"10.1164\/rccm.200910-1506OC"},{"key":"key-10.17116\/terarkh201587398-104-38","doi-asserted-by":"crossref","unstructured":"Yerkovich S.T., Hales B.J., Carroll M.L. et al. Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalization. BMC Pulm Med 2012; 12: 37.","DOI":"10.1186\/1471-2466-12-37"},{"key":"key-10.17116\/terarkh201587398-104-39","doi-asserted-by":"crossref","unstructured":"Zhang Y., Zhou B. Functions of thymic stromal lymphopoietin in immunity and disease. Immunol Res 2012; 52 (3): 211\u2014223.","DOI":"10.1007\/s12026-012-8264-z"},{"key":"key-10.17116\/terarkh201587398-104-40","doi-asserted-by":"crossref","unstructured":"Calv\u00e9n J., Yudina Y., Hallgren O. et al. Viral stimuli trigger exaggerated thymic stromal lymphopoietin expression by chronic obstructive pulmonary disease epithelium: role of endosomal TLR3 and cytosolic RIG-I-like helicases. J Innate Immun 2012; 4 (1): 86\u201499.","DOI":"10.1159\/000329131"},{"key":"key-10.17116\/terarkh201587398-104-41","doi-asserted-by":"crossref","unstructured":"Lee H.-C., Headley M.B., Loo Y.-M. et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol 2012; 130: 1187\u20141196.","DOI":"10.1016\/j.jaci.2012.07.031"},{"key":"key-10.17116\/terarkh201587398-104-42","doi-asserted-by":"crossref","unstructured":"Brandelius A., Persson I.M., Calv\u00e9n J. et al. Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors. Br J Pharmacol 2013; 168 (2): 363\u2014374.","DOI":"10.1111\/j.1476-5381.2012.02131.x"},{"key":"key-10.17116\/terarkh201587398-104-43","doi-asserted-by":"crossref","unstructured":"Blamoun A.I., Batty G.N., Debari V.A. et al. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract 2008; 62: 1373\u20141378.","DOI":"10.1111\/j.1742-1241.2008.01731.x"},{"key":"key-10.17116\/terarkh201587398-104-44","doi-asserted-by":"crossref","unstructured":"Hirota T., Takahashi A., Kubo M. et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 2011; 43: 893\u2014896 10.1038\/ng.887.","DOI":"10.1038\/ng.887"},{"key":"key-10.17116\/terarkh201587398-104-45","doi-asserted-by":"crossref","unstructured":"Baines K.J., Hsu A.C.-Y., Tooze M. et al. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respir Res 2013; 14 (1): 15.","DOI":"10.1186\/1465-9921-14-15"},{"key":"key-10.17116\/terarkh201587398-104-46","doi-asserted-by":"crossref","unstructured":"Miller E.K., Hernandez J.Z., Wimmenauer V. et al. A mechanistic role for type III IFN-\u03bb1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med 2012; 185 (5): 508\u2014516.","DOI":"10.1164\/rccm.201108-1462OC"},{"key":"key-10.17116\/terarkh201587398-104-47","doi-asserted-by":"crossref","unstructured":"Van Ly D., Faiz A., Jenkins C. et al. Characterising the mechanism of airway smooth muscle b2 adrenoceptor desensitization by rhinovirus infected bronchial epithelial cells. PLoS ONE 2013; 8 (2): e56058.","DOI":"10.1371\/journal.pone.0056058"},{"key":"key-10.17116\/terarkh201587398-104-48","doi-asserted-by":"crossref","unstructured":"Kuo C., Lim S., King N.J.C. et al. Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology 2011; 16: 367\u2014377.","DOI":"10.1111\/j.1440-1843.2010.01918.x"},{"key":"key-10.17116\/terarkh201587398-104-49","doi-asserted-by":"crossref","unstructured":"49. Foronjy R.F., Dabo A.J., Taggart C.C. et al. Respiratory Syncytial Virus Infections Enhance Cigarette Smoke Induced COPD in Mice. PLoS One 2014; 9 (2): e90567.","DOI":"10.1371\/journal.pone.0090567"},{"key":"key-10.17116\/terarkh201587398-104-50","unstructured":"Karaulov A.V., Kalyuzhin O.V. Immunoterapiya infektsionnykh boleznei: problemy i perspektivy. Ter arkh 2013; 11: 100\u2014108."},{"key":"key-10.17116\/terarkh201587398-104-51","unstructured":"Karaulov A.V., Kalyuzhin O.V. Immunotropnye preparaty: printsipy primeneniya i klinicheskaya effektivnost'. M.: MTsFER; 2007."},{"key":"key-10.17116\/terarkh201587398-104-52","unstructured":"Kozlov I.G. Kriticheskii vzglyad na rynok immunomodulyatorov v Rossii. Ross vestn perinat pediatr 2009; 4: 94\u201499."},{"key":"key-10.17116\/terarkh201587398-104-53","unstructured":"Braido F., Tarantini F., Ghiglione V. et al. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. Int J Chron Obstruct Pulmon Dis 2007; 2 (3): 335\u2014345."},{"key":"key-10.17116\/terarkh201587398-104-54","doi-asserted-by":"crossref","unstructured":"Sprenkle M.D., Niewoehner D.E., MacDonald R. et al. Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review. COPD 2005; 2: 167\u2014175.","DOI":"10.1081\/COPD-200050674"},{"key":"key-10.17116\/terarkh201587398-104-55","doi-asserted-by":"crossref","unstructured":"Steurer-Stey C., Bachmann L.M., Steurer J., Tram\u00e8r M.R. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest 2004; 126: 1645\u20141655.","DOI":"10.1378\/chest.126.5.1645"},{"key":"key-10.17116\/terarkh201587398-104-56","doi-asserted-by":"crossref","unstructured":"Cazzola M., Anapurapu S., Page C.P. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis. Pulm Pharmacol Ther 2012; 25 (1): 62\u201468.","DOI":"10.1016\/j.pupt.2011.11.002"},{"key":"key-10.17116\/terarkh201587398-104-57","unstructured":"Macchi A., Vecchia L.D. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections. Arzneim Forsch 2005; 55: 276\u2014281."},{"key":"key-10.17116\/terarkh201587398-104-58","unstructured":"RossiS., Tazza R. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. Arzneim. Forsch 2004; 54: 50\u201456."}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T21:23:21Z","timestamp":1593379401000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2015\/3\/downloads\/ru\/230040-366020150317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["terarkh201587398-104"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201587398-104","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}